Laser photocoagulation for neovascular age-related macular degeneration (Q24244141)

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Grid laser treatment of occult choroidal neovascularization in age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: ii. quality of life outcomes submacular surgery trials pilot study rep

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Argon laser treatment of pigment epithelial detachments and of subretinal neovascular membranes in Junius-Kuhnt's senile disciform macular degeneration. A prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

The effects of red krypton and green argon laser on the foveal region. A clinical and experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

CME review: A cost-utility analysis of laser photocoagulation for extrafoveal choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Prevalence of age-related macular degeneration in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Limited macular translocation: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Pegaptanib for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Transpupillary thermotherapy for occult subfoveal choroidal neovascularization: a 1-year, prospective randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

The Wisconsin age-related maculopathy grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

The management of subfoveal choroidal neovascular membranes and hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Influence of age-related maculopathy on visual functioning and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Radiotherapy for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Risk factors for age-related macular degeneration: Pooled findings from three continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

21 January 2018

Macular translocation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Photodynamic therapy for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

Earliest symptoms caused by neovascular membranes in the macula

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

7 January 2021

Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

7 January 2021

Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

7 January 2021

Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

7 January 2021

Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

7 January 2021

Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

7 January 2021

Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

7 January 2021

Classification of choroidal neovascularization by digital indocyanine green videoangiography.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

7 January 2021

Treatment of senile disciform macular degeneration: a single-blind randomised trial by argon laser photocoagulation. The Moorfields Macular Study Group

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004763.PUB2

7 January 2021